Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E K Geissler

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Transplantation Proceedings|August 5, 2009
Fighting malignancy in organ transplant recipientsE K Geissler
Transplantation Proceedings|December 23, 2008
The impact of mTOR inhibitors on the development of malignancyE K Geissler
Transplantation Proceedings|November 25, 2010
Can immunosuppressive strategies be used to reduce cancer risk in renal transplant patients?E K Geissler
Gut|December 5, 2008
Immunosuppression for liver transplantationE K Geissler, H J Schlitt
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
Soluble donor MHC class I antigen inhibits immunologic priming in vitro and in vivoE K Geissler, M N Scherer, C Graeb
Transplantation|October 6, 1997
Secreted donor-MHC class I antigen prolongs liver allograft survival and inhibits recipient anti-donor cytotoxic T lymphocyte responsesE K Geissler, W J Korzun, C Graeb
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Soluble donor MHC class I gene transfer to thymus promotes allograft survival in a high-responder heart transplant modelE K Geissler, M N Scherer, C Graeb
Mucosal Immunology|December 17, 2008
Cytokines mediating the induction of chronic colitis and colitis-associated fibrosisS Fichtner-Feigl, W Strober, E K Geissler, et al.
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|October 2, 2003
[Prevention of early rejection by soluble MHC class I antigen after allogenic liver transplantation]E K Geissler, M N Scherer, K W Jauch, et al.
Human Immunology|July 31, 1998
Immunologic suppression mediated by genetically modified hepatocytes expressing secreted allo-MHC class I moleculesC Graeb, M N Scherer, S J Knechtle, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Transplantation Proceedings|August 5, 2009
Fighting malignancy in organ transplant recipientsE K Geissler
Transplantation Proceedings|December 23, 2008
The impact of mTOR inhibitors on the development of malignancyE K Geissler
Transplantation Proceedings|November 25, 2010
Can immunosuppressive strategies be used to reduce cancer risk in renal transplant patients?E K Geissler
Gut|December 5, 2008
Immunosuppression for liver transplantationE K Geissler, H J Schlitt
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
Soluble donor MHC class I antigen inhibits immunologic priming in vitro and in vivoE K Geissler, M N Scherer, C Graeb
Transplantation|October 6, 1997
Secreted donor-MHC class I antigen prolongs liver allograft survival and inhibits recipient anti-donor cytotoxic T lymphocyte responsesE K Geissler, W J Korzun, C Graeb
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Soluble donor MHC class I gene transfer to thymus promotes allograft survival in a high-responder heart transplant modelE K Geissler, M N Scherer, C Graeb
Mucosal Immunology|December 17, 2008
Cytokines mediating the induction of chronic colitis and colitis-associated fibrosisS Fichtner-Feigl, W Strober, E K Geissler, et al.
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|October 2, 2003
[Prevention of early rejection by soluble MHC class I antigen after allogenic liver transplantation]E K Geissler, M N Scherer, K W Jauch, et al.
Human Immunology|July 31, 1998
Immunologic suppression mediated by genetically modified hepatocytes expressing secreted allo-MHC class I moleculesC Graeb, M N Scherer, S J Knechtle, et al.
Pageof 5